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Compliance, satisfaction and adherence to antihypertensive treatment
when initiating a combined therapy: what are their respective respon-
sibilities for the failure of previous treatment? OPERA study
Francois Allaert (1), Caroline Auvray (2)
(1) Chaire d'évaluation médicale, Dijon, France – (2) Laboratoire Bou-
chara-Recordati, Direction médicale, Levallois, France
Objective: when initiating a fixed dose combination therapy in hyperten-
sive patients, to identify among the causes of the failure of the previous mono-
therapy which responsibility could be respectively attributed to compliance,
adherence and patient satisfaction 
Method: cross-sectional observational pharmacoepidemiological survey
conducted by a representative sample of cardiologists. Each physician
included the four consecutive hypertensive patients inadequately controlled
with a monotherapy treatment and requiring a second treatment under the
form of a fixed dose combination therapy as it is now recommended by the
guidelines of the European Society of Hypertension (ESH ). Evaluation Cri-
teria: Previous compliance evaluated by Morisky scale (Morisky HTA), adher-
ence to the previous treatment by the adherence estimator of MacHorney
(DMRA) and satisfaction with the previous treatment by the TSQM (Treat-
ment Satisfaction Questionnaire Medication).
Results: 433 cardiologists included 1292 patients, mean age 64 years, male
57.7%. SBP was 160±12 mmHg and DBP was 91±8 mmHg. According
Moriski score, 54.6% had a poor compliance, 40.9% a moderate compliance
and 4.6% good compliance. The DRMA adherence estimator showed a low
risk of poor adherence in 39.2% of the patients, a medium risk in 28.8% and
high risk in 32.0%. The TSQM efficiency was 63±14, the TSQM tolerance
74±24 the TSQM convenience 64±16 and TSQM global satisfaction 55±20.
The Moriski score, the DRMA adherence estimator and the different subscores
of the TSQM were strongly correlated (p <0.0001).
Conclusion: The failure of the previous antihypertensive treatment results
are due to a lack of compliance but moreover to a lack of adherence of the
patients to their hypertensive treatment that they perceive more as a constraint
than a necessity. When switching to a combination therapy, patient adherence
to their antihypertensive therapy should be optimized by focusing on well tol-
erated fixed combinations 
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Remote monitoring on uncontrolled hypertension: blood pressure
assessment, optimization of treatment and measurement of variability
on 200 patients
Patrick Dary 
Cabinet de Cardiologie, Saint Yrieix La Perche, France
Purpose: This study aims to evaluate the benefit of remote monitoring of
blood pressure (BP) by self measurement to optimize treatment according to
the levels observed and to analyze variability
Methods: The patient is included when non controlled hypertension is
identified. 2 measurements taken morning, midday and evening at fixed times,
transmitted via a secure server to a medical center. If the average remains
higher than 140/90 after 5 days then the treatment phase begins
Results: 
Study Group: 
– 200 out patients(107 women, 93 men), mean age 68 (20-92)
– Duration of study: June 2011-Dec 2012
– 37% treated for dyslipidemia, 21% with atrial fibrillation and 17% dia-
betic
– Drug classes: 21% none, 21% single, 26% two and 32% combination of
three or more
BP: at the beginning of the study, average BP=175/ 93. After 4.7 days and
28 measurements the average drops to 157/84. 2 groups identified according
to the means: 
– 45 patients normal BP (22.5%): 161/90 at the start, drops to 134/77
– 155 non controlled patients (77.5%): 179/94 at the start drops to 163/86.
6 patients stop the follow-up, 149 continue to treatment phase:
– Therapeutic adaptation achieved in 12 days
– Evidence of significant drop in BP to 144/79: –19 systolic, –7 diastolic
(p<0.0001)
– 2 groups: 61 leveled out (132/80), 89 remain high (153/78)
Variability: systolic BP of all measures are lowest at midday: 157 morning,
147 midday (-10 mm, p< 0.0001), 155 evening, greatest difference in the over
75 years: -13 mm (–9 mm <75 yrs). Variability in BP (standard deviation) was
usually determined over a few days
Conclusions: Remote monitoring is a simple, fast method for gathering BP
information enabling adapted treatment according to need with a significant
systolic reduction of 19 mm (p<0.001) and improved BP control. The midday
values are significantly lower than those of the morning (–10 mm), particu-
larly for the old. Monitoring of variability of BP is straightforward and a
useful tool for evaluating risk.
Table
219
Lack of systolic arterial stiffening in vascular Ehlers-Danlos syndrom
Tristan Mirault (1), Michael Frank (2), Mathieu Pernot (3), Mathieu
Couade (3), Juliette Albuisson (2), Ralph Niarra (4), Michel Azizi (4),
Mickael Tanter (3), Xavier Jeunemaitre (2), Emmanuel Messas (1)
(1) Hôpital Européen Georges Pompidou (HEGP), Médecine Vasculaire,
Paris, France – (2) Hôpital Européen Georges Pompidou (HEGP), Centre
de référence des maladies vasculaires rares, Paris, France – (3) ESPCI –
ParisTech, Institut Langevin, Paris, France – (4) Hôpital Européen
Georges Pompidou (HEGP), Centre d'investigations cliniques, Paris,
France
Background: Vascular Ehlers-Danlos sd (vEDS) results from autosomic
dominant mutations in COL3A1 (type III collagen). Impaired mechanical
properties of the arterial wall could expose patients to arterial rupture at young
age. Arterial pulse wave velocity (PWV) is known to be correlated to arterial
stiffness. We tested whether arterial stiffness could be impaired in vEDS using
Sphygmocor for carotid-femoral PWV (cf PWV) and ultrasound Ultrafast
imaging (UF) technique for the local carotid PWV. UF, a new non-invasive
tool with high temporal resolution can assess the local carotid arterial stiffness
variation during the cardiac cycle by measuring the carotid PWV at early and
end-systole
Methods: cf PWV by Sphygmocor and Righ (RC) or Left Carotid (LC)
PWV by UF were performed on 30 vEDS patients & 102 controls. 3 acqui-
sitions (1000 images/s frame rate) were performed on RC & LC using a
conventional linear ultrasonic probe (8MHz) connected to an ultrafast
scanner. The arterial wall tissue velocities were computed off-line from
which the two local carotid PWVs at early and end-systole were derived.
January 16th, Thursday 2014
Results telemonitoring
RESULTS BP Controlled BP Not controlled Stopping Follow up
Number 45 149 6
Inclusion 161/90 179/94 176/103
Observation 134/77 163/86 175/91
Treatment – 144/79 –
BP: blood pressure
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cf PWV was acquired according to actual recommandations. Results are
mean±SD
Results: Patients only differed from controls on age (35.5 vs 45.0y,
p=0.03) and weight (55.8 vs 69.8kg, p<10-4) but not on sex ratio, systolic or
diastolic blood pressures (BP), nor heart rate. The adjusted (age, sex, weight,
BP) carotid PWV and cf PWV did not differ between patients and controls in
early systole (6.1±1.7 vs 5.2±1.9 m/s, p=0.07 for RC PWV; 5.4±1.4 vs
4.8±1.2 m/s, p =0.94 for LC PWV; 7.6±1.7 vs 7.3±1.8 m/s, p=0.69 for cf
PWV). But the increase of carotid PWV from early to end-systole was
reduced in patients (7.1% vs 26.3% in RC (p=0.013) and 9.9% vs 25.1% in
LC (p=0.043))
Conclusion: We found a weaker systolic increase of PWV in vEDS
patients which could reflect a less adaptative arterial wall stiffening during the
cardiac cycle. This may explain the higher susceptibility to arterial rupture in
vEDS patients
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Cardiovascular screening in the future: can novice physicians use poc-
ket-size ultrasound to screen abdominal aorta aneurysms? 
Tiphaine Bonnafy (1), Thomas Cautres (2), Anaïs Labrunie (3), Benoît
Marin (3), Ileana Desormais (1), Philippe Vignon (4), Philippe Lacroix (1),
Victor Aboyans (5)
(1) CHU Limoges, Hôpital Dupuytren, CTCV, Limoges, France – (2) CHU
Limoges, Hôpital Dupuytren, Service de Cardiologie, Limoges, France –
(3) Faculté de Médecine de Limoges, UFRCB, Limoges, France – (4) CHU
Limoges, Service de Réanimation, Limoges, France – (5) CHU Limoges,
Cardiologie, Limoges, France
Purpose: Several guidelines, including those in France, are in favor of
the ultrasound screening of abdominal aortic aneurysm (AAA) in population
at risk. However, AAA is still is poorly implemented. To improve the rates
of AAA screening in our country, the commitment of physicians other than
cardiovascular imaging specialists appears necessary. Besides, the use of
pocket-size ultrasound devices (PSU) seems an appealing alternative to
conventional echography machines for large-scale screening in the future.
We hypothesized that, after a short specific training with a pocket-size ultra-
sound machine, novice physicians could measure reliably the abdominal
aorta.
Methods: After a short training (6 hours) of 5 novice physicians, we
assessed the abdominal aortic diameters measurement agreement between
novice physicians with a PSU, as compared to experts using conventional
machines. The abdominal aortas of 56 patients unknown for their aorta sizes
were prospectively measured at least by 4 different observers, blinded to each
other: twice by experts with conventional ultrasound, once by an expert using
PSU and at least once by a novice with a PSU.
Results: The intra-class correlation coefficient between the four sets of
measurement was > 0.91 (Table) ; the mean difference of the measurements
was negligible (<1mm). The inter-observer variability was ≤ 4 mm in 92% of
cases. No learning curve over time was noted.
Conclusion: The diameter of the abdominal aorta can be accurately mea-
sured by non-specialist physicians with pocket-size ultraound after a short
period of training. This approach should be considered for the implementation
of national AAA screening programs.
Table. Intra-correlation coefficient between observers
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Preoperative aortic pulse wave velocity is predictive of outcome after
coronary artery bypass grafting.
Thomas Cautres (1), Philippe Lacroix (2), Aurélien Leclerc (2), Jean-
Philippe Marsaud (3), Elisabeth Cornu (2), Dania Mohty (1), Marc Laskar (2),
Victor Aboyans (4)
(1) CHU Limoges, Hôpital Dupuytren, Service de Cardiologie, Limoges,
France – (2) CHU Limoges, Hôpital Dupuytren, CTCV, Limoges, France –
(3) CHU Limoges, Hôpital Dupuytren, Service d'Anesthésiologie, Limoges,
France – (4) CHU Limoges, Cardiologie, Limoges, France
Background: Aortic stiffness (ASt) is an important predictor of cardiovascular
events in patients with coronary artery disease (CAD), but the prognostic implica-
tions of ASt in patients undergoing coronary artery bypass grafting (CABG) has
never been assessed. We hypothesized that the non-invasive assessment of ASt by
the measurement of carotid-femoral pulse wave velocity (CF-PWV) would be of
interest to stratify the perioperative risk of patients undergoing CABG.
Methods: We consecutively measured the pre-operative CF-PWV in
141 men and 37 women undergoing elective CABG in our institution. Patients
were classified according to the quartiles of CF-PWV. The primary outcome
was 30-days mortality. 
Results: Among the 178 patients (mean age: 67±9.6 years, 79.2% males)
enrolled, 12 (6.7%) died during the first month. A sharp mortality increase
was found in those within the 4th quartile (Q4) of CF-PWV (>12 m/s) com-
pared to the 3 other lower quartiles (Q1-3) (18.6% vs. 3.2%, p < 0.0025). In
multivariate analysis (figure), an elevated CF-PWV was independently associ-
ated 30-days mortality (Q4 vs. Q1-3: OR= 6.7; 95%CI: 1.01-44.31). For every
1 m/s increase of PWV, the risk of mortality was increased by 27% (p < 0.05).
Conclusion: The measurement of carotid-femoral PWV can identify a sub-
group of patients at higher risk of post-operative mortality after coronary
bypass grafting surgery, independently of other known prognostic factors. 
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Comparison of coronary heart disease and stroke risks attributable to
vascular risk factors: results from the Prime study
Vanina Bongard (1), Marie Bodenant (2), Jean Dallongeville (3), Domi-
nique Arveiler (4), Frank Kee (5), Michèle Montaye (3), Jean-Bernard
Ruidavets (1), Aline Wagner (4), Alun Evans (5), Jean Ferrières (6)
(1) CHU, UMR1027 INSERM/University School of Medicine Toulouse III,
Epidemiology, Toulouse, France – (2) Pasteur Institute of Lille, U744
Inserm – UDSL; EA1046, University Hospital, Dpt of Neurology, Lille,
France – (3) Pasteur Institute of Lille, INSERM U744, UDSL,University
of Lille Nord de France, Department of Epidemiology and Public Health,
Expertize/
Machine
Expert 1/
Conventional
Expert 2/
Conventional
Expert 3/PSU
Expert2/
Conventional
097 (0.94-0.98) – –
Expert3/PSU 094 (0.89-0.96) 0.94(0.90-0.97) –
Novice/PSU 090 (0.84-0.94) 0.92 (0.88-0.96) 0.92(0.86-0.96)
Q1
1 (ref) 0.93
1.83
8,3
p < 0.005
0
2
4
6
CF-PWV quartiles Mortality rates
OR
M
or
ta
lit
y 
ra
te
s
A
ge
- 
an
d 
se
x-
ad
ju
st
ed
 O
R
8
10
12
14
16
18
20
0
1
2
3
4
5
6
7
8
9
10
Q2 Q3 Q4
Figure – Mortality rates and risk according to CF-PWV.
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Lille, France – (4) University of Strasbourg, Medical Faculty, EA 3430,
Department of Epidemiology and Public Health, Strasbourg, France – (5)
UKCRC Centre of Excellence for Public Health, Belfast, Royaume-Uni –
(6) CHU Rangueil, Service de Cardiologie B, Toulouse, France
Background and purpose: Coronary heart disease (CHD) and stroke are
the leading causes of death worldwide, although these are preventable dis-
eases. In order to set priorities for public health policies, we sought to assess
and compare within a single cohort, CHD and stroke populationattributable
risks (PARs) for various cardiovascular risk factors.
Methods: The PRIME study is a multicenter prospective population-based
cohort of men living in France or Northern Ireland, aged 50-59 in 1991-93,
and followed over 10 years to record CHD (coronary death, myocardial infarc-
tion (MI), and unstable angina) and stroke.
Results: The sample comprised 9701 men, free of CHD and stroke at base-
line. During the followup, 410 and 118 cases of CHD and stroke occurred.
After adjustment for age, centre, antihypertensive and lipid-lowering treat-
ments, alcohol consumption and other significant cardiovascular risk factors,
PARs for CHD were 21.1% (high blood pressure), 14.8% (smoking), 11.1%
(hypercholesterolemia), 9.8% (low HDL-cholesterol), 5.4% (obesity) and
1.9% (diabetes). The overall PAR for CHD, referring to the presence of at
least one of the above detailed risk factors reached 71.2% (79.1% for coronary
death and MI). Adjusted PARs for stroke were 32.8% (high blood pressure),
15.9% (smoking) and 6.4% (diabetes), with no significant impact of the other
risk factors. The overall PAR for stroke was 43.7% (44.6% for ischemic
stroke).
Conclusions: The impact of traditional cardiovascular risk factors on CHD
and stroke are different. As prevention should primarily focus on factors
exhibiting high PARs for both diseases, high blood pressure and smoking are
the best targets.
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Cadiovascular variability and spontaneous baroreflex sensitivity in
type 2 diabetes (experience in Morraccan patients) 
Zineb El Honsali, Meryem Alj, Faima Waderrahmane
CHU Ibn Rochd, Casablanca, Maroc
Enhanced sympathetic activity is a potential cause of increased risk of car-
diovascular complications during treatment in type 2 diabetes. Spectral anal-
ysis of heart rate and blood pressure has considerable potential in assessing the
role of autonomic nervous system fluctuations in healthy individuals and
patients, as well as spontaneous baroreflex sensitivity (SBS) by means of the
α index. The aim of the present study was to investigate if type 2 diabete
without diagnosis of autonomic neuropathy is accompanied by alterations in
cardiovascular variability and SBS.
Methods: Spectral analysis of RR interval and blood pressure variability
were obtained during undisturbed supine rest in 7 healthy control subject
(controls) and 7 patients with type 2 diabetes without diagnosis of autonomic
neuropathy.The two group were matched for BMI and age. 
Result: type 2 diabete without diagnosis of autonomic neuropathy had
shorter RR interval (804±46 ms) compared with controls (939±37ms,
p<0.001for both comparisons). In type 2 diabete without diagnosis of auto-
nomic neuropathy total variance of RR was reduced (493±162 ms,p<0.05)
and spectral analysis of RR variability showed an increased low frequency
normalized units (75±5. p<0.02, index of sympathetic modulation) a
decreased high frequency normalized units (25±5, p<0.001, index of vagal
modulation) compared with control as well as an increased LF/HF ratio
(3.1±0.9, p<0.001) systolic blood pressure variance in type 2 diabete without
diagnosis of autonomic neuropathy was twofold greater than in controls
(31±8, p<0.007) as well as reduced the LF component (5±0.5 mmHg²,
p<0.0036). α index was significantly reduced in type 2 diabete without diag-
nosis of autonomic compared with controls (5.9± 0.4 and 11±2 ms/mmHg
respectively, p<0.003) 
Conclusion: type 2 diabete without diagnosis of autonomic neuropathy is
characterized by increase in cardiac and vasomotor sympathetic drive. The
increased sympathetic activity and decreased of SBS may play an important
role in the development of hypertension as well as may represents and
increase cardiovascular risk in patients with type 2 diabete 
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Characteristics and outcome of patients hospitalized for lower extre-
mity peripheral artery disease in France and receiving betabloc-
kers.The COPART registry
Tristan Mirault (1), Alexandre Galloula (1), Jean-Pierre Cambou (2), Victor
Aboyans (3), Philippe Lacroix (3), Joël Constans (4), Aude Rossi (1),
Audrey Stansal (1), Alessandra Bura-Rivière (2), Emmanuel Messas (1)
(1) Hôpital Européen Georges Pompidou (HEGP), Médecine Vasculaire,
Paris, France – (2) CHU Rangueil, Départment de Médecine Vasculaire,
Toulouse, France – (3) CHU Limoges – Hôpital Dupuytren, Départment
de Médecine Vasculaire, Limoges, France – (4) CHU Bordeaux, Départ-
ment de Médecine Vasculaire, Bordeaux, France
Background: Lower extremity peripheral artery diseases (PAD) is a
source of disability and is often associated with other cardiovascular diseases.
Although beta-blockers may be required for associated coronary artery disease
their use in PAD is still controversial, suspected of worsening the PAD. Our
goal was to assess the prescription of beta-blockers at admittance and dis-
charge of patients hospitalized for PAD and to analyze their effect on mor-
bidity and mortality at one year, from the COPART Registry, a prospective
multicenter study with patients consecutively recruited from vascular medicine
departements of 4 academic hospitals in France between 2006 and 2010.
Methods: COPART registry included patients >18 years, with either inter-
mittent claudication associated with an abnormal ABI, and/or an arterial ste-
nosis >50% or ischaemic rest pain, or ulceration and gangrene or acute lower-
limb ischaemia. We compared characteristics and outcome between patients
with or without bêtablocker (BB) at admittance and at discharge.
Results: Among the 1267 patients of the COPART registry, 328 (26%)
were treated with BB at admittance. History of blood hypertension and acute
myocardial infarction (AMI) were independent factors for BB prescription
(OR 2.60 and 3.02; p <10-4, respectively). At discharge, only AMI history
favored prescription of BB (OR 3.11, P <10-4). History of chronic obstructive
pulmonary disease and PAD with ulcer had a negative relationship with pre-
scription of BB at admittance (OR: 0.57 and 0.55 ; p<0.05, respectively) and
discharge (OR: 0.57 and 0.64 ; p<0.05, respectively). 1-year-mortality of
patients with BB did not differ from thoose without (22.7% vs 22.5%;
p=0.954; OR 1.08 95%CI [0.77-1.5]). Concerning the 1-year-amputation rate
no difference was found neither: 4.0% of patients with BB vs 6.2% without
(p=0.142) OR 0.63 95%CI [0.33-1.19].
Conclusion: Patients hospitalized for PAD can safely carry on with their
BB treatment with no increase of 1-year-mortality nor 1-year-amputation rate.
Base on these safety data prospective study should be conducted to assess the
effect of BB on long-term mortality in PAD
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Contributions of transcutaneous oxygen pressure at exercise in eva-
luating buttocks and calf intermittent claudication related to periphe-
ral arterial disease: comparison with ankle-brachial index.
Jerome Hourdain (1), Michel Bartoli (1), Pierre Abraham (2), Pierre
Edouard Magnan (1), Gabrielle Sarlon (1)
(1) Hôpital la Timone, Marseille, France – (2) CHU Angers, Explorations
fonctionnelles vasculaires, Angers, France
Objective: Measurement of post exercice ankle-brachial index (ABI),
diagnostic reference method of intermittent claudication related to peripheral
arterial disease (PAD), has limitations.This study aims to compare transcuta-
neous oxygen pressure (TCPO2) to ABI in the etiologic diagnosis of intermit-
tent claudication.
Methods: A prospective inclusion of 15 patients, with symptoms of inter-
mittent claudication, carrying at least one arterial lesion on CT (>50%) of the
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